BX Swiss TOP 30 CHF
1.207,34
PKT
+1,09
PKT
+0,09
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.01.21 | Holcim overweight | Morgan Stanley | |
| 22.01.21 | Roche overweight | Barclays Capital | |
| 22.01.21 | Novartis Underweight | Barclays Capital | |
| 22.01.21 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 21.01.21 | Holcim overweight | JP Morgan Chase & Co. | |
| 21.01.21 | Swiss Re Halten | DZ BANK | |
| 21.01.21 | UBS Outperform | Credit Suisse Group | |
| 21.01.21 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 20.01.21 | Holcim overweight | Barclays Capital | |
| 20.01.21 | Holcim buy | UBS AG | |
| 20.01.21 | Holcim buy | UBS AG | |
| 20.01.21 | Novartis Neutral | Credit Suisse Group | |
| 20.01.21 | Roche Neutral | Credit Suisse Group | |
| 20.01.21 | Novartis buy | Jefferies & Company Inc. | |
| 20.01.21 | Roche buy | Jefferies & Company Inc. | |
| 19.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.01.21 | Nestlé buy | Goldman Sachs Group Inc. | |
| 18.01.21 | Holcim Hold | Jefferies & Company Inc. | |
| 18.01.21 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 15.01.21 | Roche Hold | Deutsche Bank AG | |
| 15.01.21 | Novartis buy | Deutsche Bank AG | |
| 15.01.21 | UBS Equal weight | Barclays Capital | |
| 15.01.21 | UBS Underweight | Barclays Capital | |
| 15.01.21 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 15.01.21 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 14.01.21 | Novartis buy | UBS AG | |
| 14.01.21 | Zurich Insurance overweight | Barclays Capital | |
| 14.01.21 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.01.21 | Zurich Insurance overweight | Morgan Stanley | |
| 13.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 13.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 13.01.21 | Nestlé Sector Perform | RBC Capital Markets | |
| 12.01.21 | Givaudan Underperform | Bernstein Research | |
| 12.01.21 | Roche buy | UBS AG | |
| 12.01.21 | Nestlé buy | UBS AG | |
| 12.01.21 | Swiss Re Neutral | Credit Suisse Group | |
| 12.01.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 12.01.21 | Nestlé overweight | JP Morgan Chase & Co. | |
| 12.01.21 | Givaudan Neutral | JP Morgan Chase & Co. |